Holen Sie sich die Stockscreener-App
0.905
7.20%
-0.0702
Handel nachbörslich:
.91
0.005
+0.55%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LXRX?
Forum
Prognose
Aktiensplit
Finanzdaten der Lexicon Pharmaceuticals Inc-Aktie (LXRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
60.97%
1.13
|
0.702 | 0.162 | 0.317 | -62.31 |
| Cost Of Revenue |
55.71%
0.031
|
0.07 | 0.007 | 0.008 | - |
| Gross Profit |
73.89%
1.099
|
0.632 | 0.155 | 0.309 | 0.023 |
Operating Expenses
|
1.98%
46.43
|
47.37 | 49.79 | 44.55 | -31.17 |
| Benefits Costs and Expenses |
2.06%
46.46
|
47.44 | 49.79 | 44.56 | -30.37 |
| Costs And Expenses |
2.06%
46.46
|
47.44 | 49.79 | 44.56 | -31.17 |
| Operating Income/Loss |
3.00%
-45.33
|
-46.74 | -49.63 | -44.24 | -31.14 |
| Income/Loss From Continuing Operations Before Tax |
3.00%
-45.33
|
-46.74 | -49.63 | -44.90 | -31.93 |
| Income/Loss From Continuing Operations After Tax |
2.73%
-48.40
|
-49.76 | -50.52 | -44.90 | -31.93 |
|
Net Income/Loss
|
2.73%
-48.40
|
-49.76 | -50.52 | -44.90 | -31.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,960%
245.39
|
8.018 | 244.93 | 204.78 | 189.01 |
| Diluted Average Shares |
2,960%
245.39
|
8.018 | 244.93 | - | - |
| Basic Earnings Per Share |
0.00%
-0.20
|
-0.20 | -0.21 | -0.22 | -0.17 |
| Diluted Earnings Per Share |
0.00%
-0.20
|
-0.20 | -0.21 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):